Safety study of donor stem cell treatment for lung disease
Part of Immune system & allergy, Lungs & breathing clinical trials.
This early study tests whether donor stem cells made from umbilical cord tissue are safe in people with lung diseases. If you qualify, you may be offered the study treatment while the team closely checks for side effects and safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a lung (pulmonary) disease
- You are able and willing to sign a written consent form
- You do not have an active (ongoing) infection
- You do not have cancer that is currently being treated or active
- You are not pregnant, and you follow birth-control rules if you could become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an infusion of donor stem cells can help people with moderate to severe COPD breathe easier. If you are a current or former smoker aged 40 to 80, your symptoms are stable, and your lung function meets specific targets, you may be able to join.
This study tests a new treatment made from small mobile stem cells, given by inhalation, for people with moderate to severe COPD caused by smoking or pollution. It aims to see if the treatment is safe and helps improve lung function.
This Phase 1 study tests whether a treatment made from donated umbilical cord “exosomes” is safe in people with Parkinson’s disease. It mainly looks at side effects and safety, and could help guide future treatments if it proves tolerable.
This trial tests a treatment made from human umbilical cord stem cells for people with moderate ARDS. The goal is to see if it is safe and well-tolerated, and if it might help the lungs recover faster.
This study follows lung health after a stem cell transplant from a donor, to understand and manage chronic graft-versus-host disease (a condition where donor cells attack the body). It may help people who are about to have their first donor transplant.
This trial tests whether adding umbilical cord stem cells to standard triple therapy can help people with Group E COPD. It aims to see if this approach improves lung function and quality of life.
Hear when a new Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.